AzTrials
AzTrials

Coronary Artery DiseaseNCT01622387

Radial Artery Versus Saphenous Vein Patency (RSVP) Trial - 10 Year Follow-up

A study testing Coronary artery bypass (CABG) surgery using a radial arterial conduit and Coronary artery bypass surgery using a long saphenous vein conduit in people with Coronary Artery Disease, run by Imperial College London at 1 site in United Kingdom.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

During coronary bypass surgery, veins are taken from the leg and applied to the heart and aorta to 'bypass' narrowings in the coronary arteries. However using an artery in the chest, the internal mammary artery, means that the bypass lasts longer than using veins. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Coronary Artery Disease
What is being tested?
Coronary artery bypass (CABG) surgery using a radial arterial conduit and Coronary artery bypass surgery using a long saphenous vein conduit
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited Kingdom
Study dates
13 Oct 2011to 3 Jul 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Included in the RSVP study
  • Willing to attend for coronary angiography
  • Willing to give written informed consent

Who cannot join

  • Contraindication to coronary angiography
  • participation in research project within previous 60 days
  • unwilling to give written informed consent

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Royal Brompton & Harefield NHS Foundation Trust

    London, SW3 6NP

Other trials in United Kingdom

About this study

Official title: Randomised, Controlled Trial Comparing Angiographic Patency of the Radial Artery Versus the Saphenous Vein Used as Free Aorto-coronary Grafts in Coronary Revascularisation (RSVP Trial) - 10-year Follow-up

During coronary bypass surgery, veins are taken from the leg and applied to the heart and aorta to 'bypass' narrowings in the coronary arteries. However using an artery in the chest, the internal mammary artery, means that the bypass lasts longer than using veins. The investigators recently showed that using an artery from the arm as a bypass vessel, the radial artery, also had less furring up than veins 5 years after surgery. Now the investigators would like to ask patients to come back for an angiogram 10 years following surgery.

Being tested
Coronary artery bypass (CABG) surgery using a radial arterial conduit, Coronary artery bypass surgery using a long saphenous vein conduit
Keywords
Coronary artery bypass surgery, Arteries, Veins, Conduits
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coronary artery bypass (CABG) surgery using a radial arterial conduitProcedure or surgery

    Use of radial artery as a bypass conduit/graft to the left circumflex coronary artery region of the heart in CABG surgery

  • Coronary artery bypass surgery using a long saphenous vein conduitProcedure or surgery

    Use of long saphenous vein as a graft/conduit vessel to the left circumflex coronary artery region of the heart in CABG surgery

Study groups in NCT01622387
Study groupRoleWhat they receive
Radial arteryExperimentalUse of the radial artery as a conduit in CABG surgery
Receives: Procedure: Coronary artery bypass (CABG) surgery using a radial arterial conduit
Long saphenous veinActive comparatorUse of long saphenous vein as a conduit in CABG surgery
Receives: Procedure: Coronary artery bypass surgery using a long saphenous vein conduit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of radial artery and saphenous vein grafts patent at 10 years

    Comparison of the patency of radial artery and long saphenous aorto-coronary bypass grafts at 10 years, assessed by an independent observer

    Measured: 10 years post surgery

Secondary outcomes (2)
  1. Angiographic visual grading

    Compare secondary angiographic visual grading in radial artery and long saphenous vein grafts

    Measured: 10 years post surgery

  2. Patency (patent or complete occlusion, and secondary visual grading) of radial artery and internal mammary artery coronary bypass grafts

    Compare the patency (patent or complete occlusion, and secondary visual grading) of radial artery and internal mammary artery coronary bypass grafts

    Measured: 10 years post surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2012 (estimated)
  2. Study start13 Oct 2011
  3. Primary completion3 Jul 2014
  4. Study completion3 Jul 2014

Why it stopped: No funding

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01622387
Sponsor's protocol ID
P38558
Status last verified
Aug 2015
First submitted
22 Mar 2012
Last updated
1 Mar 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Coronary artery bypass (CABG) surgery using a radial arterial conduit and Coronary artery bypass surgery using a long saphenous vein conduit in people with Coronary Artery Disease, run by Imperial College London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 1 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of radial artery and saphenous vein grafts patent at 10 years (time frame: 10 years post surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in